Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system |
BNF code | 0703011A0AAAAAA |
Virtual Therapeutic Moiety | Ethinylestradiol + Etonogestrel |
Abbreviated name | Ethinylest 2.7mg/Etonogestrel 11.7mg vaginal delivery system |
Basis of preferred name | Other |
Date of name applicability | 15 Jun 2010 |
Previous name | Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system |
Basis of previous name | Other |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | system |
Unit dose unit of measure | system |
Virtual Product Ingredient | |
---|---|
Ingredient | Ethinylestradiol |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 2.700 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Etonogestrel |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 11.700 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | deliverysystem.vaginal |
Dose Form | |
Formulation | Vaginal delivery system |
Drug Route | |
Route | Vaginal |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) | |
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) | |
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) | |
Virtual Medicinal Product Packs | |
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system 3 system |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.